Healthcare Is Being Rewritten: CVS Breaks Up as Big Pharma Bets Billions on the Obesity Revolution
The global healthcare industry is undergoing a major transformation as CVS Health prepares to split its healthcare empire, while pharmaceutical giants intensify their pursuit of the booming obesity market. Eli Lilly is expanding direct digital access to its weight-loss medicines, and AstraZeneca has reportedly pursued a multibillion-dollar deal for Rhythm Pharmaceuticals. Together, these developments reveal a healthcare landscape increasingly shaped by corporate specialization, metabolic medicine, digital distribution, consumer access and enormous pharmaceutical investment opportunities worldwide.